Bioscience Managers Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 7
- Investments
- 35
- Portfolio
- 19
- Exits
- 13
Bioscience Managers General Information
Description
Founded in 2003, Bioscience Managers is a venture capital firm headquartered in Melbourne, Australia. The firm seeks to invest in the healthcare, technology, life sciences, and manufacturing sectors.
Contact Information
Website
www.biosciencemanagers.com
Formerly Known As
Octa Phillip Bioscience Managers
Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Investment Bank
PE/Buyout
Primary Office
- Level 10
- 330 Collins Street
- Melbourne, Victoria 3000
- Australia
+61 (03) 0000 0000
Bioscience Managers Investments (35)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Immunosis | 01-Jan-2021 | Later Stage VC | Diagnostic Equipment | Startup | ||
| 00000 | 20-Dec-2020 | 0000 | 000.00 | Pharmaceuticals | Generating Revenue/Not Profitable | |
| 000000 00000000000 | 11-Dec-2020 | 0000 | 0000 | Biotechnology | Profitable | |
| 000000 0000 000000 | 22-Nov-2020 | 00000 00000 | 00.00 | Therapeutic Devices | Startup | 000000 000000 00.0 |
| 000000 0000000 | 15-Nov-2020 | 00000 00000 | Other Healthcare Technology Systems | Generating Revenue | ||
| 0000000000000 | 30-Oct-2019 | 00000 00000 | 00.000 | Educational Software | Generating Revenue | |
| 0000000000 | 08-Aug-2019 | 00000 00000 | 00.000 | Distributors/Wholesale | Generating Revenue | 000000 000000 00.0 |
| 000000000000000 00 | 04-Jun-2019 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | |
| Canary Medical | 31-May-2019 | Later Stage VC | 0000 | Other Healthcare Technology Systems | Generating Revenue | |
| Congenica | 30-Apr-2019 | Later Stage VC | 000.00 | Decision/Risk Analysis | Generating Revenue |
Bioscience Managers Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Arecor | 03-Jun-2021 | IPO | 000.00 |
| 000 0000000000000 | 06-Apr-2021 | 000000000000000000 | |
| 000000 00000000000 | 10-May-2019 | 0000000 000000 | |
| 0000000 000000 | 04-Sep-2017 | 000 | 000.00 |
| 00000000 | 26-Aug-2015 | 000 | 000.00 |
| 0000000 | 05-Feb-2015 | 000 | 0000 |
| 0000000 000000 | 15-Oct-2014 | 000 | 00000 |
| 000000000 00000000 | 01-Apr-2007 | 000000000000000000 | |
| Acrux | 29-Sep-2004 | IPO | 000.00 |
| Alchemia | 23-Dec-2003 | IPO | 000.00 |
Bioscience Managers Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialBioscience Managers Team (16)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Alan Cainey | Chief Financial Officer, Company Secretary and Board of Director | Melbourne, Australia | |||
| Amanda Gillon Ph.D | Managing Director | 0 | 0 | 0 | Melbourne, Australia |
| Mandeep Dhillon Ph.D | Principal | Melbourne, Australia | |||
| Geoff Brooke | Investment Advisor | 0 | Melbourne, Australia | ||
| Kathryn Rowley Ph.D | Investment Director | 0 | 0 | 0 | London, United Kingdom |
Bioscience Managers Co-Investors (36)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Downing Ventures | 7 | 0 | 0 |
|
|
| Amadeus Capital Partners | 0 |
|
|
||
| Cambridge Angels | 0 |
|
|
||
| EPIC Investment Partners | 0 | 0 |
|
|
|
| Midven | 0 |
|
|